Logo

American Heart Association

  26
  0


Final ID: MP618

Lp(a) Screening in FQHCs: A National Implementation Science Approach

Abstract Body (Do not enter title and authors here): Background
Lipoprotein (a) [Lp(a)] is genetically inherited, causal and prevalent risk factor for Atherosclerotic Cardiovascular Disease (ASCVD). Despite a 10%−20% prevalence of elevated Lp(a), utilization of Lp(a) testing in clinical practice has been long felt to be poor. Elevated Lp(a), which is (≥50 mg/dL or ≥ 125 nmol/L), can increase the risk of heart attack, stroke, and peripheral artery disease. About 20-30% of people worldwide have high Lp(a), with the highest levels in Black/African American and South Asian populations.
Methods
The American Heart Association’s Lp(a) FQHC Discovery Project applies implementation science to evaluate innovative quality improvement strategies, aiming to analyze Lp(a) testing trends and increase testing in Federally Qualified Health Centers (FQHCs) through data-driven initiatives. Baseline and monthly testing data was collected via Qualtrics to monitor progress and assess potential gaps in Lp(a) care continuums. Improvement efforts were discussed in monthly consults. Additionally, FQHCs shared knowledge and best practices during learning collaboratives.
Results
A total of ten sites were enrolled, with participants submitting baseline data from June 2023 through May 2024. During the first three quarters of the intervention, sites averaged 407 tests ordered and 131 values recorded per quarter, a 13.6-fold and 5.2-fold increase, respectively, compared to baseline. One-third (n=308) of recorded Lp(a) values were high (≥50 mg/dL). Black/African American patients had the highest Lp(a) values. While 43% of patients were Black/African American, they accounted for 70% of Lp(a) values between 70–89 mg/dL and 61% of values ≥90 mg/dL.
Conclusion
Findings showed that implementation science approaches can effectively enhance Lp(a) screening and awareness in FQHCs, resulting in increased testing. This project also highlights higher Lp(a) levels amid Black/African American patients, emphasizing the need for targeted education and risk management strategies. These results underscore the importance of sustained quality improvement, patient engagement and equity-focused approaches to ASCVD prevention.
  • Gooden, Kelly  ( AHA , Hoover , Alabama , United States )
  • Pena, David  ( American Heart Association , Georgetown , Texas , United States )
  • Gonzalez, Nicole  ( American Heart Association , Washington , District of Columbia , United States )
  • Emmons-bell, Sophia  ( American Heart Association , Austin , Texas , United States )
  • Skinner, Jeremy  ( American Heart Association , HOUSTON , Texas , United States )
  • Colson, Kristin  ( American Heart Association , Boise , Idaho , United States )
  • Author Disclosures:
    Kelly Gooden: DO NOT have relevant financial relationships | David Pena: DO NOT have relevant financial relationships | Nicole Gonzalez: DO NOT have relevant financial relationships | Sophia Emmons-Bell: No Answer | Jeremy Skinner: DO NOT have relevant financial relationships | Kristin Colson: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

From Systems to Solutions: Innovation, Equity, and Implementation at the Frontlines of Cardiovascular Care

Saturday, 11/08/2025 , 10:45AM - 11:55AM

Moderated Digital Poster Session

More abstracts on this topic:
Barriers Associated with The Use of Smart Blood Pressure Monitors Among Minority Older Adults

Sun Jany, Dong Yanjun, Boliboun Jimmie, Koo Katherine, Vazquez-trejo Valeria, Cui Michael, Rizzo Victoria, Rowe Jeannine


A blood test based on RNA-seq and machine learning for the detection of steatotic liver disease: A Pilot Study on Cardiometabolic Health

Poggio Rosana, Berdiñas Ignacio, La Greca Alejandro, Luzzani Carlos, Miriuka Santiago, Rodriguez-granillo Gaston, De Lillo Florencia, Rubilar Bibiana, Hijazi Razan, Solari Claudia, Rodríguez Varela María Soledad, Mobbs Alan, Manchini Estefania

More abstracts from these authors:
Lipoprotein (a) Discovery Project: Assessing Patient and Professional Education Needs

Yuan Meg, Groom Allison, Collins Eliana, Peña David, Colson Kristin, Skinner Jeremy, Congdon Michelle, Pressley Alyssa

Supporting High Schools in Implementing CPR Training: The Ohio CPR in Schools Program

Emmons-bell Sophia, Higbie Amber, Wakefield-wilson Yolana, Dewolf Cindie, Tolbert Emily

You have to be authorized to contact abstract author. Please, Login
Not Available